Recent Investment Analysts’ Ratings Updates for Alignment Healthcare (ALHC)

Alignment Healthcare (NASDAQ: ALHC) has recently received a number of price target changes and ratings updates:

• 3/6/2025 – Alignment Healthcare had its price target raised by analysts at JPMorgan Chase & Co. from $14.00 to $17.00. They now have a “neutral” rating on the stock.
• 3/4/2025 – Alignment Healthcare had its price target raised by analysts at Piper Sandler from $14.00 to $21.00. They now have an “overweight” rating on the stock.
• 3/4/2025 – Alignment Healthcare had its price target raised by analysts at Bank of America Co. from $15.50 to $18.50. They now have a “buy” rating on the stock.
• 2/28/2025 – Alignment Healthcare had its price target raised by analysts at Barclays PLC from $8.00 to $9.00. They now have an “underweight” rating on the stock.
• 2/28/2025 – Alignment Healthcare had its “outperform” rating reaffirmed by analysts at William Blair.
• 2/28/2025 – Alignment Healthcare had its price target raised by analysts at Stifel Nicolaus from $16.00 to $18.00. They now have a “buy” rating on the stock.
• 2/24/2025 – Alignment Healthcare had its “overweight” rating reaffirmed by analysts at Stephens. They now have a $17.00 price target on the stock.
• 1/14/2025 – Alignment Healthcare had its price target raised by analysts at Stifel Nicolaus from $14.00 to $16.00. They now have a “buy” rating on the stock.

Alignment Healthcare Stock Performance

NASDAQ ALHC traded down $0.55 during trading on Thursday, reaching $15.26. The company’s stock had a trading volume of 714,015 shares, compared to its average volume of 1,996,075. Alignment Healthcare, Inc. has a twelve month low of $4.46 and a twelve month high of $16.25. The business’s fifty day moving average price is $13.80 and its 200-day moving average price is $12.12. The company has a debt-to-equity ratio of 1.82, a quick ratio of 1.60 and a current ratio of 1.60. The firm has a market cap of $2.93 billion, a price-to-earnings ratio of -19.82 and a beta of 1.50.

Insider Buying and Selling at Alignment Healthcare

In other Alignment Healthcare news, President Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock in a transaction that occurred on Tuesday, February 18th. The shares were sold at an average price of $13.72, for a total value of $411,600.00. Following the completion of the sale, the president now directly owns 1,576,097 shares of the company’s stock, valued at approximately $21,624,050.84. The trade was a 1.87 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, COO Sebastian Burzacchi sold 8,550 shares of the stock in a transaction on Tuesday, December 10th. The stock was sold at an average price of $11.26, for a total value of $96,273.00. Following the transaction, the chief operating officer now directly owns 217,395 shares in the company, valued at approximately $2,447,867.70. This represents a 3.78 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 378,428 shares of company stock valued at $5,009,324. Corporate insiders own 6.60% of the company’s stock.

Institutional Investors Weigh In On Alignment Healthcare

Institutional investors have recently added to or reduced their stakes in the company. R Squared Ltd purchased a new stake in shares of Alignment Healthcare in the fourth quarter worth about $55,000. RiverPark Advisors LLC bought a new stake in Alignment Healthcare during the fourth quarter valued at $106,000. Tower Research Capital LLC TRC grew its holdings in shares of Alignment Healthcare by 146.7% during the fourth quarter. Tower Research Capital LLC TRC now owns 10,571 shares of the company’s stock valued at $119,000 after purchasing an additional 6,286 shares during the last quarter. Ballentine Partners LLC bought a new stake in Alignment Healthcare in the fourth quarter valued at $121,000. Finally, Connor Clark & Lunn Investment Management Ltd. bought a new position in Alignment Healthcare in the 3rd quarter worth about $131,000. Hedge funds and other institutional investors own 86.19% of the company’s stock.

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.